Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M » 08:39 09/29/22 09/29 08:39 09/29/22 08:39 TTOO T2 Biosystems / + T2 Biosystems announced… T2 Biosystems announced that the Biomedical Advanced Research and Development Authority, BARDA, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing an additional $3.7M in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems. The total potential BARDA funding if all contract options are exercised is $62M, reflecting a reduction in the scope of work under contract option 3. The additional funding will be used to advance the U.S. clinical trials for the T2Resistance Panel and T2Biothreat Panel and file submissions to the U.S. Food and Drug Administration for U.S. regulatory clearance. "We are pleased to advance the U.S. clinical trials for the T2Resistance Panel and T2Biothreat Panel, in collaboration with BARDA, and subsequently file submissions with FDA for U.S. regulatory clearance," stated John Sperzel, Chairman and CEO of T2 Biosystems. "These new products will expand the test menu on our T2Dx Instrument and have the potential to reduce the threat of antimicrobial resistance and protect the nation from biothreat pathogens." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TTOO T2 Biosystems / + 09/22/22 T2 Biosystems announces commercial expansion though distributor in Baltic Region 08/16/22 T2 Biosystems seeks shareholder approval for reverse stock split 08/09/22 T2 Biosystems to explore potential to develop test for Monkeypox virus 07/11/22 T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 08/15/22 T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 10/11/22 T2 Biosystems, Inc.

Over a week ago
Hot Stocks	T2 Biosystems announces commercial expansion though distributor in Baltic Region » 16:20 09/22/22 09/22 16:20 09/22/22 16:20 TTOO T2 Biosystems / + T2 Biosystems announced… T2 Biosystems announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through the distributor. The execution of this exclusive distribution agreement further expands T2 Biosystems' commercialization. Epidemiology studies have shown that the Baltic region has a higher average incidence of sepsis per population than Western Europe.1 There have been national guidelines in the region to address the impact of sepsis.2 The introduction of the T2Dx Instrument and sepsis panels into these countries will allow rapid detection of sepsis-causing pathogens and antibiotic resistance genes, in hours instead of days, enabling clinicians to achieve targeted therapy, faster. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TTOO T2 Biosystems / + 08/16/22 T2 Biosystems seeks shareholder approval for reverse stock split 08/09/22 T2 Biosystems to explore potential to develop test for Monkeypox virus 07/11/22 T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel 07/06/22 T2 Biosystems implements expense reductions including workforce reduction TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 08/15/22 T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 10/11/22 T2 Biosystems, Inc.

Over a month ago
Hot Stocks	T2 Biosystems seeks shareholder approval for reverse stock split » 07:51 08/16/22 08/16 07:51 08/16/22 07:51 TTOO T2 Biosystems / + In a regulatory filing,… In a regulatory filing, T2 Biosystems gave notice that its 2022 annual meeting of stockholders will be held on Tuesday, October 11, at which the company will ask shareholders to approve an amendment to the company's restated certificate of incorporation to effect a reverse stock split of the company's common stock at a reverse split ratio ranging from any whole number between and including 1-for-10 and 1-for-50, with the exact ratio within such range to be determined at the discretion of the board, subject to the board of directors' authority to abandon the amendment. ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems / + 08/09/22 T2 Biosystems to explore potential to develop test for Monkeypox virus 07/11/22 T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 08/15/22 T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning
Earnings	T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year » 16:15 08/15/22 08/15 16:15 08/15/22 16:15 TTOO T2 Biosystems / + Reports Q2 revenue… Reports Q2 revenue $5.91M, consensus $6.13M. "Our second quarter results demonstrate continued execution across our three corporate priorities: accelerating our sales, enhancing our operations, and advancing our pipeline," stated John Sperzel, chairman and CEO of T2 Biosystems. "While we have seen an expected decline in sales of COVID-19 tests, we are pleased with our continued progress driving adoption of our T2Dx Instrument and sepsis test panels, while improving operating efficiency and advancing the U.S. clinical trials for the T2Resistance Panel and the T2Biothreat Panel. We strengthened our balance sheet during and subsequent to the end of the second quarter, allowing us to achieve our near-term milestones and keeping us well positioned to drive sustainable, long-term growth." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TTOO T2 Biosystems / + 08/09/22 T2 Biosystems to explore potential to develop test for Monkeypox virus 07/11/22 T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 08/15/22 T2 Biosystems - TTOO
Hot Stocks	T2 Biosystems to explore potential to develop test for Monkeypox virus » 08:39 08/09/22 08/09 08:39 08/09/22 08:39 TTOO T2 Biosystems / + T2 Biosystems announced… T2 Biosystems announced plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility. "Our team has demonstrated the scientific expertise to develop new tests on our proprietary platform, including direct-from-blood and swab tests, and we believe the development of a molecular diagnostic test for the monkeypox virus is possible on our platform," stated John Sperzel, Chairman and CEO of T2Biosystems. "Given the urgent nature of the monkeypox virus, and the potential for global transmission, we have communicated with the FDA and CDC and we are exploring the potential to develop and commercialize a test for the monkeypox virus." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TTOO T2 Biosystems / + 07/11/22 T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 08/08/22 42nd Annual Global I Growth Conference 08/15/22 T2 Biosystems - TTOO
Hot Stocks	T2 Biosystems receives FDA Breakthrough Device Designation for T2Lyme Panel » 08:06 07/11/22 07/11 08:06 07/11/22 08:06 TTOO T2 Biosystems / + T2 Biosystems announced… T2 Biosystems announced the U.S. Food and Drug Administration has granted Breakthrough Device Designation for the Company's T2Lyme Panel. The T2Lyme Panel is a direct-from-blood molecular diagnostic test designed to run on the FDA-cleared T2Dx Instrument and simultaneously detect the bacteria that cause Lyme disease: Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. The T2Lyme Panel is intended to test individuals with signs and symptoms of Lyme disease and aid in the diagnosis of early Lyme disease. ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems / + 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TTOO T2 Biosystems / + 07/07/22 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning
Downgrade	T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners » 08:49 07/07/22 07/07 08:49 07/07/22 08:49 TTOO T2 Biosystems $0.16 / -0.03 (-15.87%) Alliance Global Partners… Alliance Global Partners analyst Ben Haynor downgraded T2 Biosystems to Neutral from Buy with a price target of $0.14, down from $0.65, after the company announced a preliminary Q2 revenue miss. Based on preliminary results, he is reducing his 2022 and 2023 revenue estimates and notes that T2 now has less than two quarters of cash remaining. He does not expect to see investors move off the sidelines into the shares given its situation and the presently difficult market conditions, Haynor said. ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems $0.16 / -0.03 (-15.87%) 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TTOO T2 Biosystems $0.16 / -0.03 (-15.87%) 07/07/22 BTIG T2 Biosystems downgraded on 'broad-based' shortfall at BTIG 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners 02/18/22 Canaccord T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord TTOO T2 Biosystems $0.16 / -0.03 (-15.87%) 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems $0.16 / -0.03 (-15.87%) 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning
Downgrade	T2 Biosystems downgraded on 'broad-based' shortfall at BTIG » 07:24 07/07/22 07/07 07:24 07/07/22 07:24 TTOO T2 Biosystems / + BTIG analyst Mark Massaro… BTIG analyst Mark Massaro downgraded T2 Biosystems to Neutral from Buy without a price target after the company preannounced a Q2 shortfall. Management said the timing of system orders was one factor, but indicated they were also below their expectations on sepsis and COVID testing, which means the shortfall was broad-based, Massaro tells investors in a research note. T2 will need 56% of contribution in the back half of the year on revenue to meet guidance, a heavier weighting versus last year's 51% back-half weighting, which may prove to be challenging, says the analyst. Massaro awaits greater clarity on T2's back half operations, which he says will include updates related to financing as well as a potential remedy for a Nasdaq delisting. ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems / + 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TTOO T2 Biosystems / + 07/07/22 BTIG T2 Biosystems downgraded to Neutral from Buy at BTIG 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners 02/18/22 Canaccord T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord 01/18/22 Canaccord T2 Biosystems significantly undervalued at current levels, say Canaccord TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning
Downgrade	T2 Biosystems downgraded to Neutral from Buy at BTIG » 06:43 07/07/22 07/07 06:43 07/07/22 06:43 TTOO T2 Biosystems / + BTIG analyst Mark Massaro… BTIG analyst Mark Massaro downgraded T2 Biosystems to Neutral from Buy. ShowHide Related Items >><< Company News Street Research Earnings On The Fly TTOO T2 Biosystems / + 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TTOO T2 Biosystems / + 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners 02/18/22 Canaccord T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord 01/18/22 Canaccord T2 Biosystems significantly undervalued at current levels, say Canaccord TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TTOO T2 Biosystems / + 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning
On The Fly	What You Missed On Wall Street On Wednesday » 16:12 07/06/22 07/06 16:12 07/06/22 16:12 AMZN Amazon.com $114.19 / +0.635 (+0.56%) , TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) , MSFT Microsoft $265.97 / +3.1 (+1.18%) , ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) , MO Altria Group $41.09 / -0.625 (-1.50%) , RFP Resolute Forest $20.34 / +7.85 (+62.85%) , $ECON Economic Data / + , SPX S&P 500 / + , SPY SPDR S&P 500 ETF Trust $382.99 / +1.02 (+0.27%) , RKT Rocket Companies $8.38 / +0.32 (+3.97%) , RNG RingCentral $55.37 / -5.86 (-9.57%) , COIN Coinbase $51.76 / -3.625 (-6.55%) , ENTA Enanta $51.26 / -1.54 (-2.92%) , UHS Universal Health $102.27 / -2.59 (-2.47%) , HCA HCA Healthcare $166.48 / -6.04 (-3.50%) , MAR Marriott $135.50 / -3.21 (-2.31%) , VIVHY Vivendi $9.47 / -0.06 (-0.63%) , LGF.A Lionsgate $8.35 / -0.365 (-4.19%) , LGF.B Lionsgate $7.93 / -0.295 (-3.59%) , CWK Cushman & Wakefield $14.84 / -0.91 (-5.78%) , PINC Premier $37.00 / +1.21 (+3.38%) , PTON Peloton $10.14 / -0.27 (-2.59%) , VERU Veru $13.02 / +1.51 (+13.12%) , RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) , TLRY Tilray $3.49 / +0.265 (+8.22%) , WISH ContextLogic $1.63 / -0.15 (-8.45%) , DASH DoorDash $69.19 / -5.7 (-7.61%) , UBER Uber $21.44 / -1.09 (-4.84%) , KRNT Kornit Digital $23.24 / -8.31 (-26.34%) , RADA Rada Electronic $7.70 / -1.33 (-14.73%) , TTOO T2 Biosystems / + , ARTW Art's Way $2.35 / -0.46 (-16.37%) , SFET Safe-T / + Get caught up quickly on… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis WISH VERU UHS UBER TTOO TLRY TKAYY SPX SFET RNG RKT RIVN RFP RADA PTON PINC MSFT MO MAR LGF.A KRNT HCA ENTA DASH CWK COIN ATVI AMZN $ECON WISH ContextLogic $1.63 / -0.15 (-8.45%) 07/05/22 EPA orders ContextLogic to stop selling several unregistered disinfectants 06/24/22 ContextLogic set to join Russell 3000 Index 05/19/22 ContextLogic director sells $3.7M in common stock 05/11/22 ContextLogic announces inducement grants under Nasdaq listing rule VERU Veru $13.02 / +1.51 (+13.12%) 07/06/22 Veru's sabizabulin shows reduction of COVID-19 deaths in published trial 06/07/22 Veru submits EUA application to FDA for sabizabulin 06/06/22 Tang Capital reports 5.2% passive stake in Veru 06/06/22 Veru presents final results from Phase 1b/2 study of sabizabulin UHS Universal Health $102.27 / -2.59 (-2.47%) 06/30/22 Universal Health drops 7% to $99.00 after FY22 guidance lowered 04/26/22 Universal Health falls -11.4% 04/26/22 Universal Health falls -11.8% 04/25/22 Universal Health drops 10% to $125.00 after Q1 EPS misses estimates UBER Uber $21.44 / -1.09 (-4.84%) 07/01/22 Uber releases its second US safety report 06/28/22 Group of 34 companies ask California Governor to allow autonomous trucks TTOO T2 Biosystems / + 07/06/22 T2 Biosystems implements expense reductions including workforce reduction 06/10/22 T2 Biosystems granted extension from Nasdaq to comply with bid price rule 05/20/22 T2 Biosystems announces issuance of patent for direct detection of Lyme Disease 05/05/22 T2 Biosystems receives Nasdaq delisting notice TLRY Tilray $3.49 / +0.265 (+8.22%) 07/06/22 Good Supply brand expands product offering in Quebec 07/05/22 HEXO shareholders approve note transaction with Tilray 06/29/22 Tilray expands portfolio of medical cannabis products in UK 06/22/22 Tilray welcomes government of Luxembourg delegation visit to European campus TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) 07/06/22 EU carries out inspections of online food delivery companies 07/06/22 Just Eat Takeaway.com continuing to explore sale of Grubhub SPX S&P 500 / + 06/14/22 Ackman says 75 point hike tomorrow can help restore confidence in Fed 06/07/22 Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says SFET Safe-T / + 05/26/22 Safe-T secures non-dilutive line of credit from United Mizrahi-Tefahot Bank 05/19/22 Safe-T announces dismissal of NetNut's patent litigation 05/09/22 Safe-T issues letter to shareholders from CEO Daniel 03/11/22 Safe-T partners with TerraZone, DreamVPS to launch Virtual Private Workforce RNG RingCentral $55.37 / -5.86 (-9.57%) 05/09/22 RingCentral names Sonalee Parekh CFO 03/23/22 Theta Lake attracts $50M in series B funding 02/22/22 RingCentral sees Q1 EPS 34c, consensus 33c 02/22/22 RingCentral reports Q4 subscriptions revenue up 37% y/y RKT Rocket Companies $8.38 / +0.32 (+3.97%) 07/06/22 Rocket Companies rises 8.9% 07/06/22 Rocket Companies rises 9.6% 06/08/22 Rocket Companies CEO buys $599K in common stock 05/18/22 Rocket Companies CEO buys $599K in common stock RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 07/06/22 Rivian Automotive reports Q2 production of 4,401 vehicles 06/26/22 Fly Intel: Top five weekend stock stories 06/06/22 Rivian says roadmap focused so cash can support 2025 launch of R2 platform 06/06/22 Rivian Automotive to host first annual shareholder meeting RFP Resolute Forest $20.34 / +7.85 (+62.85%) 07/06/22 Resolute Forest rises 63.6% 07/06/22 Resolute Forest rises 64.8% 07/06/22 Resolute Forest rises 64.6% 07/06/22 Resolute Forest to be acquired by Paper Excellence Group for $2.7B RADA Rada Electronic $7.70 / -1.33 (-14.73%) 06/21/22 RADA Electronic trading resumes 06/21/22 RADA Electronic trading halted, news pending 06/21/22 Rada Electronic, Leonardo DRS to combine and maintain Leonardo DRS name 04/18/22 Rada Electronic reports over $29M in new business in Q1 PTON Peloton $10.14 / -0.27 (-2.59%) 06/06/22 Peloton appoints Liz Coddington CFO 05/24/22 Peloton CEO: 'You'd have to be a moron to sell equity' at this stock level 05/24/22 Peloton CEO: 'I don't care' about Connected Fitness, gross margins 05/16/22 Peloton, iFIT announce settlement of all pending litigation PINC Premier $37.00 / +1.21 (+3.38%) 04/19/22 Assure awarded intraoperative neuromonitoring services with Conductiv 03/14/22 Sodexo announces national GPO agreement with Premier MSFT Microsoft $265.97 / +3.1 (+1.18%) 07/06/22 U.K. opens competition investigation into Microsoft, Activision deal 07/05/22 EU regulators adopt new rules to monitor 'Tech Giants' 07/01/22 CWA supports Microsoft's proposed Activision Blizzard takeover in FTC letter 06/30/22 Samsung launches Gaming Hub for Samsung Smart TVs MO Altria Group $41.09 / -0.625 (-1.50%) 07/06/22 FDA suspends ban on Juul's products while vaping company appeals 06/24/22 Juul to seek stay of FDA decision, exploring 'all options' under law 06/23/22 FDA denies authorization to market JUUL products 06/23/22 FDA denies authorization to market JUUL products MAR Marriott $135.50 / -3.21 (-2.31%) 06/17/22 First Advantage expands board of directors with appointment of Price 06/12/22 Fly Intel: Top five weekend stock stories 06/06/22 Marriott launches 'Marriott's Bridging The Gap' hotel development program 06/03/22 Marriott suspends all operations in Russia due to new restrictions LGF.A Lionsgate $8.35 / -0.365 (-4.19%) 05/27/22 Lionsgate CEO expects Starz spinoff announcement by end of summer 05/17/22 Lionsgate, Great Point Studios, NJPAC partner for TV, film complex in Newark 04/26/22 Lionsgate and the Roku Channel announce theatrical output deal KRNT Kornit Digital $23.24 / -8.31 (-26.34%) 07/05/22 Kornit Digital falls 20% to $24.99 after below-consensus Q2 revenue outlook 05/16/22 Kornit Digital highlights Kornit Fashion Week London 05/11/22 Kornit Digital sees revenue stronger in Q3, Q4 vs. Q2 01/26/22 Kornit Digital announces opening of new ink manufacturing facility HCA HCA Healthcare $166.48 / -6.04 (-3.50%) 06/23/22 McKesson, HCA Healthcare to form oncology research joint venture 06/17/22 FTC issues statement on HCA Healthcare, Steward abandoning proposed merger 05/17/22 HCA Healthcare chief HR officer Berres sells 2,358 common shares 04/22/22 HCA Healthcare falls -18.2% ENTA Enanta $51.26 / -1.54 (-2.92%) 06/21/22 Enanta files patent infringement lawsuit against Pfizer 05/18/22 Enanta falls 13% after announcing EDP-938 did not meet primary endpoint 05/18/22 Enanta says EDP-938 did not meet primary endpoint in RSVP study 05/18/22 Enanta reports topline data from RSVP study of EDP-938 DASH DoorDash $69.19 / -5.7 (-7.61%) 07/06/22 DoorDash falls -8.8% 07/06/22 DoorDash falls -8.6% 06/13/22 DoorDash launches new app features to 'rate, review and discover' CWK Cushman & Wakefield $14.84 / -0.91 (-5.78%) 06/08/22 Cushman & Wakefield, Pupil enter agreement for digital property solutions 05/17/22 Cushman & Wakefield acquires Cresa Partners of Los Angeles, terms not disclosed 05/16/22 Cushman & Wakefield. Greystone close sale, financing of Hoover property 04/19/22 Greystone teams up with Greystone Monticello, Cushman & Wakefield COIN Coinbase $51.76 / -3.625 (-6.55%) 06/24/22 Coinbase Derivatives Exchange launching crypto derivatives product 06/23/22 Coinbase says investigating connectivity issues 06/23/22 Coinbase to begin sunsetting Coinbase Pro later this year 06/15/22 Crypto names fall again as bitcoin extends decline to $20,000 ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 07/04/22 Fly Intel: Top five weekend stock stories 07/01/22 Activision Blizzard closes acquisition of Proletariat AMZN Amazon.com $114.19 / +0.635 (+0.56%) 07/06/22 DoorDash, Uber slide after Amazon strikes deal with Grubhub 07/06/22 Amazon to take stake in Grubhub as part of Just Eat Takeaway.com agreement 07/06/22 Just Eat Takeaway.com, Amazon enter into commercial agreement in the U.S. 07/06/22 Amazon announces new deals for Prime members ahead of Prime Day $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting AMZN TKAYY MSFT ATVI MO RFP $ECON SPX SPY RKT RNG COIN ENTA UHS HCA MAR VIVHY LGF.A LGF.B CWK PINC PTON VERU RIVN TLRY WISH DASH UBER KRNT RADA TTOO ARTW SFET AMZN Amazon.com $114.19 / +0.635 (+0.56%) 07/06/22 Baird Baird says Amazon deal with Just Eat an efficient way to re-enter local delivery 06/29/22 JPMorgan Amazon.com price target lowered to $175 from $200 at JPMorgan 06/29/22 Redburn Microsoft initiated with a Buy at Redburn 06/29/22 Redburn Amazon.com initiated with a Buy at Redburn TKAYY Just Eat Takeaway.com $10.47 / + (+0.00%) 07/07/21 Bernstein Just Eat Takeaway.com initiated with an Outperform at Bernstein MSFT Microsoft $265.97 / +3.1 (+1.18%) 07/06/22 Needham RingCentral downgraded to Hold from Buy at Needham 06/27/22 William Blair Okta not seeing backlash from security breach, says William Blair 06/24/22 Citi Citi names top software picks with sector de-rating 'mostly done' ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 05/31/22 Benchmark Marcus, Imax, WWE added to entertainment top ideas list at Benchmark 05/06/22 Benchmark Playstudios could still be target as industry consolidates, says Benchmark 04/25/22 Benchmark Activision results for Blizzard 'somewhat shocking,' says Benchmark 04/19/22 Goldman Sachs Activision Blizzard assumed with Not Rated at Goldman Sachs MO Altria Group $41.09 / -0.625 (-1.50%) 07/01/22 Deutsche Bank Altria Group price target lowered to $46 from $60 at Deutsche Bank 06/29/22 Barclays Altria Group downgraded to Underweight from Equal Weight at Barclays 06/27/22 Cowen Altria Group price target lowered to $45 from $56 at Cowen 06/24/22 Morgan Stanley Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley RFP Resolute Forest $20.34 / +7.85 (+62.85%) 06/23/22 TD Securities Resolute Forest price target lowered to $16 from $17.50 at TD Securities 01/10/22 CIBC Resolute Forest upgraded to Outperformer from Neutral at CIBC 10/21/21 Fly Intel: Top five analyst downgrades 10/21/21 CIBC Resolute Forest downgraded to Neutral from Outperformer at CIBC $ECON Economic Data / + 07/01/22 JPMorgan JPMorgan forecast 'perilously close' to recession after GDP cuts 05/19/22 Goldman Sachs Goldman Sachs sees 35% chance of U.S. recession in next two years 02/18/22 Stifel Stifel says S&P 500 correction in Q1 isn't over 11/22/21 BTIG In picking Powell, Biden went with 'safest choice,' says BTIG SPX S&P 500 / + 06/27/22 Citi Citi cuts S&P 500 year-end target, sees positive second half setup 03/07/22 Citi Citi lowers year-end 2022 S&P 500 target on geopolitical risk SPY SPDR S&P 500 ETF Trust $382.99 / +1.02 (+0.27%) RKT Rocket Companies $8.38 / +0.32 (+3.97%) 07/06/22 Wells Fargo Wells Fargo upgrades Rocket Companies to Overweight, raises price target to $10 07/06/22 Wells Fargo Rocket Companies upgraded to Overweight from Equal Weight at Wells Fargo 06/17/22 Wells Fargo Rocket Companies price target lowered to $6.50 from $8.00 at Wells Fargo 05/31/22 Argus Rocket Companies cut to Hold at Argus on 'significantly higher' mortgage rates RNG RingCentral $55.37 / -5.86 (-9.57%) 05/23/22 Jefferies RingCentral price target lowered to $80 from $100 at Jefferies 05/18/22 Wells Fargo RingCentral price target lowered to $115 from $150 at Wells Fargo 05/16/22 Baird Baird downgrades three cloud stocks on focus shift to cash flows COIN Coinbase $51.76 / -3.625 (-6.55%) 07/06/22 Atlantic Equities Atlantic downgrades Coinbase to Neutral, lowers price target 'materially' 07/06/22 Atlantic Equities Coinbase downgraded to Neutral from Overweight at Atlantic Equities 06/27/22 Goldman Sachs Coinbase downgraded to Sell from Neutral at Goldman Sachs 06/23/22 Redburn Coinbase downgraded to Neutral from Buy at Redburn ENTA Enanta $51.26 / -1.54 (-2.92%) 07/06/22 Evercore ISI Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data 07/06/22 Evercore ISI Enanta upgraded to Outperform from In Line at Evercore ISI 07/01/22 RBC Capital Enanta price target raised to $67 from $64 at RBC Capital 06/22/22 Piper Sandler Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler UHS Universal Health $102.27 / -2.59 (-2.47%) 07/06/22 BMO Capital Universal Health downgraded to Underperform from Market Perform at BMO Capital 07/06/22 BMO Capital Universal Health downgraded to Underperform from Market Perform at BMO Capital 07/01/22 Mizuho Universal Health price target lowered to $121 from $153 at Mizuho 06/16/22 Loop Capital Loop starts Universal Health at Hold on behavioral health staffing concerns HCA HCA Healthcare $166.48 / -6.04 (-3.50%) 07/06/22 BMO Capital HCA Healthcare downgraded to Underperform from Market Perform at BMO Capital 07/06/22 BMO Capital HCA Healthcare downgraded to Underperform from Market Perform at BMO Capital 07/01/22 Mizuho HCA Healthcare price target lowered to $210 from $260 at Mizuho 06/21/22 RBC Capital HCA Healthcare price target lowered to $256 from $267 at RBC Capital MAR Marriott $135.50 / -3.21 (-2.31%) 06/28/22 Barclays Marriott initiated with an Overweight at Barclays 05/04/22 Stifel Marriott price target raised to $180 from $175 at Stifel 02/16/22 Truist Marriott price target raised to $182 from $156 at Truist 02/16/22 Deutsche Bank Marriott price target raised to $164 from $150 at Deutsche Bank VIVHY Vivendi $9.47 / -0.06 (-0.63%) 04/26/22 Credit Suisse Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse 04/25/22 JPMorgan Vivendi price target raised to EUR 13.60 from EUR 13.30 at JPMorgan 04/11/22 Credit Suisse Vivendi price target raised to EUR 13.10 from EUR 13 at Credit Suisse 03/16/22 Deutsche Bank Vivendi price target lowered to EUR 14 from EUR 15 at Deutsche Bank LGF.A Lionsgate $8.35 / -0.365 (-4.19%) 06/03/22 Deutsche Bank Lionsgate price target lowered to $13 from $16 at Deutsche Bank 06/02/22 Wolfe Research Lionsgate initiated with an Outperform at Wolfe Research 04/19/22 Rosenblatt Lionsgate initiated with a Buy at Rosenblatt 02/07/22 Cowen Lionsgate price target lowered to $17 from $21 at Cowen LGF.B Lionsgate $7.93 / -0.295 (-3.59%) 01/31/22 Truist Lionsgate price target raised to $18 from $16 at Truist 01/04/22 Wells Fargo Wells Fargo upgrades Lionsgate to Overweight, raises price target to $25 CWK Cushman & Wakefield $14.84 / -0.91 (-5.78%) 04/21/22 Citi Cushman & Wakefield price target lowered to $21 from $23 at Citi 04/05/22 Goldman Sachs Cushman & Wakefield initiated with a Buy at Goldman Sachs 03/10/22 Wolfe Research Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research 12/01/21 Morgan Stanley Cushman & Wakefield price target raised to $23.75 from $21.75 at Morgan Stanley PINC Premier $37.00 / +1.21 (+3.38%) 05/04/22 Canaccord Premier price target lowered to $44 from $47 at Canaccord 05/04/22 Piper Sandler Premier upgraded to Overweight from Neutral at Piper Sandler 04/13/22 Guggenheim Premier initiated with a Neutral at Guggenheim 03/31/22 Credit Suisse Premier assumed with an Underperform at Credit Suisse PTON Peloton $10.14 / -0.27 (-2.59%) 06/29/22 JPMorgan Peloton price target lowered to $20 from $24 at JPMorgan 06/28/22 Stifel Peloton price target lowered to $13 from $14 at Stifel 06/17/22 Evercore ISI Peloton price target lowered to $14 from $20 at Evercore ISI 06/07/22 Citi Peloton CFO well positioned to manage subscriber growth, says Citi VERU Veru $13.02 / +1.51 (+13.12%) 07/06/22 Jefferies Veru data likely portend FDA authorization in 30 days, says Jefferies 05/18/22 Brookline Veru price target raised to $31 from $29 at Brookline 05/13/22 Jefferies Veru price target raised to $55 from $33 at Jefferies 04/12/22 Oppenheimer Veru price target raised to $36 from $25 at Oppenheimer RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 07/06/22 RBC Capital Rivian Automotive's Q2 deliveries stronger than expected, says RBC Capital 07/06/22 Baird Rivian Q2 production update a 'step in the right direction,' says Baird 06/30/22 RBC Capital RBC confident in Rivian Automotive achieving Q2 delivery estimates 06/27/22 Mizuho Rivian Automotive price target lowered to $70 from $80 at Mizuho TLRY Tilray $3.49 / +0.265 (+8.22%) 06/24/22 Cantor Fitzgerald Cantor upgrades Aurora to Overweight on potential catalyst in Germany 06/16/22 Canaccord Hexo downgraded to Hold at Canaccord on faltering turnaround prospects 06/15/22 Alliance Global Partners Hexo downgraded to Neutral from Buy at Alliance Global Partners 06/15/22 Canaccord Tilray price target lowered to $7 from $9 at CanaccordHexo WISH ContextLogic $1.63 / -0.15 (-8.45%) 03/22/22 Loop Capital ContextLogic cut to Hold at Loop Capital on inflation and and European exposure 03/22/22 Loop Capital ContextLogic downgraded to Hold from Buy at Loop Capital 12/02/21 Fly Intel: Top five analyst downgrades 12/02/21 UBS ContextLogic assumed with Neutral from Buy at UBS DASH DoorDash $69.19 / -5.7 (-7.61%) 07/07/22 Citi DoorDash price target lowered to $118 from $138 at Citi 06/29/22 JPMorgan DoorDash price target lowered to $90 from $100 at JPMorgan 06/27/22 Needham DoorDash price target lowered to $100 from $140 at Needham 06/21/22 Goldman Sachs DoorDash reinstated with a Neutral at Goldman Sachs UBER Uber $21.44 / -1.09 (-4.84%) 06/29/22 JPMorgan Uber price target lowered to $48 from $60 at JPMorgan 06/29/22 Wedbush Uber assumed with an Outperform at Wedbush 06/24/22 Wolfe Research Uber price target lowered to $27 from $30 at Wolfe Research 06/16/22 Mizuho Uber hits 'speed bump' in Massachusetts, says Mizuho KRNT Kornit Digital $23.24 / -8.31 (-26.34%) 07/06/22 Craig-Hallum Craig-Hallum downgrades Kornit Digital to Hold, lowers price target to $26 07/06/22 Needham Kornit Digital price target lowered to $38 from $75 at Needham 07/06/22 Craig-Hallum Kornit Digital downgraded to Hold from Buy at Craig-Hallum 07/06/22 Citi Kornit Digital price target lowered to $50 from $90 at Citi RADA Rada Electronic $7.70 / -1.33 (-14.73%) 05/10/22 Alliance Global Partners Rada Electronic price target lowered to $13 from $14 at Alliance Global 04/19/22 Canaccord Rada Electronic price target raised to $19 from $14 03/17/22 Alliance Global Partners Rada Electronic downgraded to Neutral from Buy at Alliance Global Partners 01/12/22 Canaccord Rada Electronic price target lowered to $14 from $16 at Canaccord TTOO T2 Biosystems / + 02/18/22 Alliance Global Partners T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners 02/18/22 Canaccord T2 Biosystems price target lowered to $1.50 from $3.00 at Canaccord 01/18/22 Canaccord T2 Biosystems significantly undervalued at current levels, say Canaccord ARTW Art's Way $2.35 / -0.46 (-16.37%) SFET Safe-T / + 01/31/22 Safe-T initiated with a Buy at Dawson James 09/23/21 Alliance Global Partners Safe-T initiated with a Buy at Alliance Global Partners WISH VERU UHS UBER TTOO TLRY SFET RNG RKT RIVN RFP RADA PTON PINC MSFT MO MAR LGF.A KRNT HCA ENTA DASH CWK COIN ATVI ARTW AMZN $ECON WISH ContextLogic $1.63 / -0.15 (-8.45%) 03/01/22 ContextLogic reports Q4 EPS (9c), consensus (9c) VERU Veru $13.02 / +1.51 (+13.12%) 05/12/22 Veru reports Q2 EPS (18c), consensus (15c) 02/09/22 Veru reports Q1 EPS (8c), consensus (12c) UHS Universal Health $102.27 / -2.59 (-2.47%) 06/30/22 Universal Health cuts FY22 adjusted EPS view to $9.60-$10.40 from $11.90-$12.90 06/30/22 Universal Health sees Q2 adjusted EPS $2.05-$2.15, consensus $2.79 04/25/22 Universal Health reports Q1 adjusted EPS $2.15, consensus $2.46 04/25/22 Notable companies reporting after market close UBER Uber $21.44 / -1.09 (-4.84%) 05/04/22 Uber reports Q1 EPS ($3.04), consensus (24c) 02/09/22 Uber reports Q4 EPS 44c, consensus (35c) 02/09/22 Uber reports Q4 revenue $5.78B, consensus $5.34 02/09/22 Notable companies reporting after market close TTOO T2 Biosystems / + 07/06/22 T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M 07/06/22 T2 Biosystems sees Q2 revenue $5.8M-$6.1M, consensus $6.87M 05/05/22 T2 Biosystems backs FY22 revenue view $28M-$31M, consensus $29.47M 05/05/22 T2 Biosystems reports Q1 EPS (10c), consensus (7c) TLRY Tilray $3.49 / +0.265 (+8.22%) 04/06/22 Tilray reports Q3 EPS 9c vs. ($1.03) last year 01/10/22 Tilray reports Q2 revenue $155M vs. $129M last year SFET Safe-T / + 07/06/22 Safe-T sees Q2 revenue $4.6M vs. $1.8M last year 05/31/22 Safe-T reports Q1 EPS (16c) vs (11c) last year 04/18/22 Safe-T sees Q1 revenue $4M vs $1.4M last year 03/29/22 Safe-T reports Q4 adjusted EPS (10c) vs. (13c) last year RNG RingCentral $55.37 / -5.86 (-9.57%) 05/09/22 RingCentral raises FY22 EPS view to $1.83-$1.87, consensus $1.71 05/09/22 RingCentral reports Q1 EPS 39c, consensus 34c 05/09/22 Notable companies reporting after market close 02/22/22 RingCentral sees FY22 EPS $1.69-$1.72, consensus $1.65 RKT Rocket Companies $8.38 / +0.32 (+3.97%) 05/10/22 Rocket Companies reports Q1 adjusted EPS 15c, consensus 19c 05/10/22 Notable companies reporting after market close 02/24/22 Rocket Companies reports Q4 adjusted EPS 32c, consensus 36c 02/24/22 Notable companies reporting after market close RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 05/11/22 Rivian Automotive reports Q1 adjusted EPS ($1.43), consensus ($1.44) 05/11/22 Notable companies reporting after market close 03/10/22 Rivian sees FY22 adjusted EBITDA ($4.75B) RFP Resolute Forest $20.34 / +7.85 (+62.85%) 05/05/22 Resolute Forest reports Q1 adjusted EPS $2.26, consensus $2.47 RADA Rada Electronic $7.70 / -1.33 (-14.73%) 07/06/22 Rada Electronic withdraws FY22 guidance 07/06/22 Rada Electronic sees Q2 revenue $22.5M, consensus 36.09M 05/10/22 Rada Electronic backs FY22 revenue view of over $140M, consensus $140.18M 05/10/22 Rada Electronic reports Q1 EPS (1c), consensus 12c PTON Peloton $10.14 / -0.27 (-2.59%) 06/20/22 Fly Intel: Top five weekend stock stories 05/10/22 Peloton sees Q4 revenue $675M-$700M, consensus $821.68M 05/10/22 Peloton reports Q3 EPS ($2.27), consensus (83c) 05/09/22 Notable companies reporting before tomorrow's open PINC Premier $37.00 / +1.21 (+3.38%) 05/03/22 Premier raises FY22 adjusted EPS view to $2.48-$2.58 from $2.45-$2.55 05/03/22 Premier reports Q3 adjusted EPS 57c, consensus 58c 02/01/22 Premier lowers FY22 adjusted EPS view to $2.45-$2.55 from $2.56-$2.66 02/01/22 Premier reports Q2 adjusted EPS 73c, consensus 65c MSFT Microsoft $265.97 / +3.1 (+1.18%) 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 04/26/22 Notable companies reporting after market close MO Altria Group $41.09 / -0.625 (-1.50%) 05/19/22 Altria Group backs FY22 adjusted EPS view $4.79-$4.93, consensus $4.86 04/28/22 Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84 04/28/22 Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18 04/27/22 Notable companies reporting before tomorrow's open MAR Marriott $135.50 / -3.21 (-2.31%) 05/04/22 Marriott reports Q1 adjusted EPS $1.25, consensus 90c 05/03/22 Notable companies reporting before tomorrow's open 02/15/22 Marriott reports Q4 adjusted EPS $1.30, consensus 99c LGF.A Lionsgate $8.35 / -0.365 (-4.19%) 05/26/22 Lionsgate reports Q4 adjusted EPS 6c, consensus (13c) 02/03/22 Lionsgate reports Q3 adjusted EPS 2c, consensus 1c KRNT Kornit Digital $23.24 / -8.31 (-26.34%) 07/05/22 Kornit Digital sees Q3 revenue 'at or above' Q2 levels 07/05/22 Kornit Digital sees Q2 revenue $56.4M-$59.4M, consensus $91.4M 05/11/22 Kornit Digital sees Q2 revenue $85M-$95M, consensus $102.04M 05/11/22 Kornit Digital reports Q1 adjusted EPS 0c, consensus 15c HCA HCA Healthcare $166.48 / -6.04 (-3.50%) 04/22/22 HCA Healthcare cuts FY22 EPS view to $16.40-$17.60 from $18.40-$19.20 04/22/22 HCA Healthcare reports Q1 EPS $4.14, consensus $4.25 01/27/22 HCA Healthcare sees FY22 EPS $18.40-$19.20, consensus $18.73 01/27/22 HCA Healthcare reports Q4 EPS $5.75, consensus $4.53 ENTA Enanta $51.26 / -1.54 (-2.92%) 05/09/22 Enanta reports Q2 EPS ($1.63), consensus ($1.43) 02/08/22 Enanta reports Q1 EPS ($1.48), consensus ($1.08) 02/08/22 Enanta reports Q1 EPS ($1.48), Bloomberg says DASH DoorDash $69.19 / -5.7 (-7.61%) 05/05/22 DoorDash reports Q1 EPS (48c), consensus (41c) 05/05/22 Notable companies reporting after market close 02/16/22 DoorDash reports Q4 EPS (45c), consensus (25c) 02/16/22 Notable companies reporting after market close CWK Cushman & Wakefield $14.84 / -0.91 (-5.78%) 05/05/22 Cushman & Wakefield reports Q1 adjusted EPS 48c, consensus 22c 02/24/22 Cushman & Wakefield reports Q4 adjusted EPS 94c, consensus 63c COIN Coinbase $51.76 / -3.625 (-6.55%) 05/10/22 Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year 05/10/22 Coinbase reports Q1 revenue $1.165B, consensus $1.48B 02/24/22 Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 04/25/22 Activision Blizzard reports Q1 EPS 64c, consensus 70c 02/03/22 Activision Blizzard reports Q4 adjusted EPS $1.01, consensus $1.31 02/03/22 Notable companies reporting after market close ARTW Art's Way $2.35 / -0.46 (-16.37%) 07/06/22 Art's Way reports Q2 EPS 4c vs. 1c last year AMZN Amazon.com $114.19 / +0.635 (+0.56%) 05/05/22 AES Corp.to provide 450 MW of renewable energy to Amazon 04/28/22 Amazon sees Q2 revenue $116B-$121B, consensus $125.55B 04/28/22 Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36 04/28/22 Notable companies reporting after market close $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 19 Nov 16 Nov 10 Nov 19 Aug 12 Aug 29 Jul VIVHY VERU UHS UBER TLRY RIVN PTON PINC MSFT MO MAR LGF.B LGF.A HCA DASH CWK COIN ATVI AMZN $ECON VIVHY Vivendi $9.47 / -0.06 (-0.63%) 07/06/22 Vivendi unit seeking stake in Lionsgate, Les Echos says 05/05/22 Vivendi's Canal Plus weighs offer for stake in Lionsgate's Starz, FT reports VERU Veru $13.02 / +1.51 (+13.12%) 05/02/22 Culper Research says shorting Veru, sees COVID-19 EUA as 'non-starter' 04/11/22 STAT's Feuerstein asks how 45% mortality rate 'possible' in Veru placebo arm UHS Universal Health $102.27 / -2.59 (-2.47%) 06/15/22 Hospitals win 340B lawsuit at Supreme Court, Modern Healthcare says UBER Uber $21.44 / -1.09 (-4.84%) 06/29/22 Waymo, others call on CA to lift ban on heavy self-driving trucks, Verge says 06/29/22 Uber raises UAE fares due to surge in gas prices, Bloomberg reports 06/23/22 Uber explored options for Indian ride-hailing unit, Bloomberg reports 06/10/22 Uber's head of rides in U.S., Canada leaving company, Insider reports TLRY Tilray $3.49 / +0.265 (+8.22%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 06/30/22 General Motors Hummer production lags offerings from Ford and Rivian, WSJ says 06/26/22 Tesla. Ford and GM raise EV prices as costs and demand grow, WSJ reports 06/25/22 Lucid stock looks more vulnerable than Tesla, other peers, Barron's says 06/14/22 Tesla CEO says rivals Rivian, Lucid 'tracking toward bankruptcy,' Electrek says PTON Peloton $10.14 / -0.27 (-2.59%) 07/06/22 Peloton offers bonuses, re-priced options to boost morale, CNBC says 06/18/22 As tech gets hammered, Oracle stock looks attractive, Barron's says 05/18/22 Peloton loan attracts strong demand from private, public lenders, FT reports 05/17/22 Peloton debt sale orders double offer size, Bloomberg reports PINC Premier $37.00 / +1.21 (+3.38%) 07/06/22 Premier hired banks earlier this year to look at strategic options, Axios says MSFT Microsoft $265.97 / +3.1 (+1.18%) 07/06/22 Nintendo Switch sales rise 24% y/y in U.K. in June, Gamesindustry.biz says 07/02/22 Activision stock is a bet worth making on Microsoft's takeover, Barron's says 07/01/22 Microsoft's Azure suffering from limited server capacity, Information reports MO Altria Group $41.09 / -0.625 (-1.50%) 06/28/22 Juul aims to extend stay on FDA's ban on its e-cigarettes, CNBC says 06/24/22 Appeals court halts FDA's ban on Juul e-cigarettes, AP reports 06/22/22 FDA to order Juul to take e-cigarettes off U.S. market, WSJ reports 06/21/22 Biden administration plans move to reduce nicotine in cigarettes, WaPo reports MAR Marriott $135.50 / -3.21 (-2.31%) 07/06/22 Marriott suffers another data breach, CyberScoop reports 06/11/22 Marriott, Southwest should do well if business travel bounces back, Barron's says 05/24/22 Marriott CEO says likely to restart share buybacks, Bloomberg reports 03/11/22 Marriott, Hilton hotels remain open in Russia, NY Post says LGF.B Lionsgate $7.93 / -0.295 (-3.59%) 05/03/22 Roku, Apollo team to bid for minority stake in Starz, WSJ reports LGF.A Lionsgate $8.35 / -0.365 (-4.19%) 06/24/22 Disney, Starz offering 'unique' bundle in Latin America, The Streamable says 05/27/22 Lionsgate CEO expects to announce Starz deal by summer end, Deadline reports HCA HCA Healthcare $166.48 / -6.04 (-3.50%) 06/16/22 HCA Healthcare abandons proposed merger with Steward Health, Bloomberg reports DASH DoorDash $69.19 / -5.7 (-7.61%) 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 03/23/22 Instacart plans to launch 15-minute grocery delivery service, Information says 03/17/22 Ride-hailing, delivery app drivers stretched amid spiking gas prices, NYT says 03/08/22 Uber, Lyft, others launch ad campaign to prevent unions, WSJ reports CWK Cushman & Wakefield $14.84 / -0.91 (-5.78%) 07/06/22 Cushman & Wakefield held in contempt of court in Trump case, CNBC reports COIN Coinbase $51.76 / -3.625 (-6.55%) 06/30/22 Coinbase seeks European licenses to boost international growth, CNBC says 06/30/22 Coinbase reportedly providing geo-location data to ICE, CoinDesk reports 06/01/22 Crypto industry sees surge in lawsuits amid investor losses, WSJ reports 05/24/22 Coinbase testing app that lets staff rate each other, Information reports ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 06/29/22 Blizzard to acquire Proletariat to work on 'World of Warcraft,' VentureBeat says 06/23/22 Blizzard's 'Overwatch 2' to replace original 'Overwatch' live service, IGN says 06/21/22 Activision holders approve public harassment reporting proposal, WaPo says AMZN Amazon.com $114.19 / +0.635 (+0.56%) 07/06/22 Amazon to share more data with competitors after EU antitrust deal, FT reports 07/05/22 Amazon,Microsoft, Google keep firm grip on cloud computing space, WSJ says 06/30/22 Amazon, Rite Aid limit purchase of emergency contraceptives, AP reports 06/29/22 Amazon moves to restrict LGBTQ-related products in UAE, NY Times says $ECON Economic Data / + 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports 03/09/22 U.S. funding bill hits snag over COVID-relief money, WSJ reports WISH VIVHY VERU UHS UBER TLRY SFET RIVN RADA PTON MSFT MO MAR LGF.A HCA ENTA DASH COIN ATVI AMZN $ECON WISH ContextLogic $1.63 / -0.15 (-8.45%) 03/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VIVHY Vivendi $9.47 / -0.06 (-0.63%) 05/05/22 What You Missed On Wall Street On Thursday VERU Veru $13.02 / +1.51 (+13.12%) 06/07/22 Fly Intel: Pre-market Movers 06/06/22 Fly Intel: After-Hours Movers UHS Universal Health $102.27 / -2.59 (-2.47%) 06/30/22 What You Missed On Wall Street On Thursday UBER Uber $21.44 / -1.09 (-4.84%) 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO TLRY Tilray $3.49 / +0.265 (+8.22%) 06/30/22 Here's What You Missed in Cannabis This Week 06/23/22 Here's What You Missed in Cannabis This Week SFET Safe-T / + 04/18/22 What You Missed On Wall Street This Morning RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 07/05/22 What You Missed This Week in EVs and Clean Energy 07/01/22 Sell these stocks now, proven algorithm says RADA Rada Electronic $7.70 / -1.33 (-14.73%) 04/18/22 What You Missed On Wall Street On Monday PTON Peloton $10.14 / -0.27 (-2.59%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 05/18/22 What You Missed On Wall Street On Wednesday MSFT Microsoft $265.97 / +3.1 (+1.18%) 07/06/22 What You Missed This Week in Video Games 07/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MO Altria Group $41.09 / -0.625 (-1.50%) 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MAR Marriott $135.50 / -3.21 (-2.31%) 05/04/22 What You Missed On Wall Street This Morning LGF.A Lionsgate $8.35 / -0.365 (-4.19%) 07/04/22 Box Office Battle: ‘Minions: The Rise of Gru’ wins weekend with record debut 06/26/22 Box Office Battle: ‘Elvis’ ties with ‘Top Gun: Maverick’ for top spot HCA HCA Healthcare $166.48 / -6.04 (-3.50%) 05/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ENTA Enanta $51.26 / -1.54 (-2.92%) 05/18/22 Fly Intel: After-Hours Movers DASH DoorDash $69.19 / -5.7 (-7.61%) 07/02/22 Opening Day: Ivanhoe Electric falls in debut after raising $169M in IPO 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO COIN Coinbase $51.76 / -3.625 (-6.55%) 07/01/22 Here's What You Missed in Crypto This Week ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 06/28/22 What You Missed This Week in Video Games AMZN Amazon.com $114.19 / +0.635 (+0.56%) 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 07/06/22 Fly Intel: Pre-market Movers 07/05/22 What You Missed On Wall Street On Tuesday $ECON Economic Data / + 06/15/22 What You Missed On Wall Street On Wednesday 05/12/22 What You Missed On Wall Street On Thursday 05/04/22 What You Missed On Wall Street On Wednesday 07/12/22 SEMICon West 2022 10/09/22 64th NABE Annual Meeting 07/13/22 Amazon.com - AMZN 07/28/22 Altria Group - MO 08/04/22 Cushman & Wakefield - CWK 08/04/22 Lionsgate - LGF.B 08/04/22 Lionsgate - LGF.A WISH VERU UHS UBER TLRY SPX RNG RKT RIVN PTON MSFT MO MAR DASH COIN ATVI AMZN WISH ContextLogic $1.63 / -0.15 (-8.45%) 05/05/22 ContextLogic options imply 13.1% move in share price post-earnings 03/07/22 Unusually active option classes on open March 7th 03/01/22 ContextLogic options imply 17.1% move in share price post-earnings 02/01/22 Unusually active option classes on open February 1st VERU Veru $13.02 / +1.51 (+13.12%) 06/27/22 Veru call volume above normal and directionally bullish 06/07/22 Veru call volume above normal and directionally bullish 06/07/22 Unusually active option classes on open June 7th 06/03/22 Veru call volume above normal and directionally bullish UHS Universal Health $102.27 / -2.59 (-2.47%) 04/25/22 Early notable gainers among liquid option names on April 25th 02/25/22 Early notable gainers among liquid option names on February 25th UBER Uber $21.44 / -1.09 (-4.84%) 06/15/22 Notable open interest changes for June 15th 05/05/22 Notable open interest changes for May 5th 05/04/22 Notable open interest changes for May 4th 04/26/22 Uber put volume heavy and directionally bearish TLRY Tilray $3.49 / +0.265 (+8.22%) 05/16/22 Tilray call volume above normal and directionally bullish 05/02/22 Put bomber drops one in Tilray 03/30/22 Tilray call volume above normal and directionally bullish 03/29/22 Largest borrow rate increases among liquid names SPX S&P 500 / + 03/31/22 $20B notional collar in SPX Quarterly options replaces expiring positions 03/30/22 $56M at-the-money call buyer in SPX April looks opening 03/25/22 Overnight activity included 3293 trades in SPX and 25 trades in VIX 03/10/22 March 4400-4600 call spread sold 10,000 at 9.00 RNG RingCentral $55.37 / -5.86 (-9.57%) 05/27/22 Ringcentral call volume above normal and directionally bullish 05/09/22 Ringcentral options imply 16.7% move in share price post-earnings 02/22/22 Ringcentral options imply 12.7% move in share price post-earnings RKT Rocket Companies $8.38 / +0.32 (+3.97%) 07/06/22 Rocket Companies call volume above normal and directionally bullish 07/06/22 Unusually active option classes on open July 6th 06/30/22 Rocket Companies call volume above normal and directionally bullish 06/27/22 Largest borrow rate increases among liquid names RIVN Rivian Automotive $29.61 / +2.74 (+10.20%) 06/21/22 Rivian call volume above normal and directionally bullish 05/24/22 Rivian put volume heavy and directionally bearish 05/18/22 Rivian call volume above normal and directionally bullish PTON Peloton $10.14 / -0.27 (-2.59%) 05/02/22 Peloton Interactive call volume above normal and directionally bullish 04/14/22 Peloton Interactive call volume above normal and directionally bullish 03/30/22 Peloton Interactive call volume above normal and directionally bullish 02/09/22 Notable open interest changes for February 9th MSFT Microsoft $265.97 / +3.1 (+1.18%) 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd 05/31/22 Microsoft call volume above normal and directionally bullish 05/02/22 Microsoft put buyer realizes 57% same-day gains MO Altria Group $41.09 / -0.625 (-1.50%) 06/23/22 Unusually active option classes on open June 23rd 06/22/22 Altria Group put volume heavy and directionally bearish 06/22/22 Unusually active option classes on open June 22nd 05/10/22 Unusually active option classes on open May 10th MAR Marriott $135.50 / -3.21 (-2.31%) 06/30/22 Marriott put volume heavy and directionally bearish 04/06/22 Marriott put volume heavy and directionally bearish 04/06/22 Unusually active option classes on open April 6th 02/04/22 Marriott put volume heavy and directionally bearish DASH DoorDash $69.19 / -5.7 (-7.61%) 06/01/22 DoorDash put volume heavy and directionally bearish 05/05/22 DoorDash options imply 13.1% move in share price post-earnings 05/05/22 Unusually active option classes on open May 5th 04/26/22 DoorDash put volume heavy and directionally bearish COIN Coinbase $51.76 / -3.625 (-6.55%) 06/22/22 Coinbase put volume heavy and directionally bearish 05/13/22 Unusually active option classes on open May 13th 05/10/22 Coinbase options imply 20.4% move in share price post-earnings 02/28/22 Coinbase call volume above normal and directionally bullish ATVI Activision Blizzard $78.32 / -0.505 (-0.64%) 05/02/22 Unusually active option classes on open May 2nd 04/25/22 Unusually active option classes on open April 25th 04/18/22 Activision Blizzard call volume above normal and directionally bullish 02/04/22 Notable open interest changes for February 4th AMZN Amazon.com $114.19 / +0.635 (+0.56%) 07/06/22 Notable open interest changes for July 6th 07/06/22 Amazon call buyer realizes 151% same-day gains 07/05/22 Notable open interest changes for July 5th 07/01/22 Notable open interest changes for July 1st SPY SPX SPY SPDR S&P 500 ETF Trust $382.99 / +1.02 (+0.27%) 07/06/22 SPDR S&P 500 ETF Trust: Pivot points 07/01/22 SPDR S&P 500 ETF Trust: Pivot points 06/30/22 SPDR S&P 500 ETF Trust: Pivot points 06/29/22 SPDR S&P 500 ETF Trust: Pivot points SPX S&P 500 / + 05/06/22 On The Fly: Weekly technical notes for S&P 500 04/29/22 On The Fly: Weekly technical notes for S&P 500 04/22/22 On The Fly: Weekly technical notes for S&P 500 04/14/22 On The Fly: Weekly technical notes for S&P 500

On The Fly

News and insights, exclusive to thefly.com

17:54	Fly Intel: After-Hours Movers»
16:27	What You Missed On Wall Street On Monday»
15:28	Fly Insider: Clear Channel, Nikola among weeks notable insider trades»
12:07	What You Missed On Wall Street This Morning»
11:34	Biotech Alert: Searches spiking for these stocks today»

View all On The Fly Stories »

Upcoming
Events (10)

	AAO 2022
	Annual Scientific Meeting 2022 of HFSA
	Annual Scientific Meeting 2022 of HFSA
	2022 Chicago Payments Symposium
ABUS ...	6th Annual Genetic Medicines Conference
	Sustainability Week
	Technology-Enabled Disruption Conference
CSTL	Castle Biosciences
SRE	Sempra Energy
LYRA	Lyra Therapeutics

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial